04 – 11 December 2016 Stopping CRISPR’s genome-editing scissors from snipping out of control Researchers have found for the first time anti-CRISPR proteins that shut off the genome editor and shown they can use them to control the cutting of DNA in human cells. Find source Studying embryos beyond 14 days? It’s a …
28 November – 04 December 2016 First new HIV vaccine efficacy study The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults. Find source Weaponized antibodies use new tricks to fight cancer After decades of frustration, efforts …
21 – 27 November 2016 Field trial of genetically modified mosquitoes gets approval in Florida A field trial of genetically modified mosquitoes has been approved in Florida, but several steps remain before the trial can actually get going. Find source NgAgo gene-editing controversy escalates Chinese researchers reported that an enzyme called NgAgo could be …
In this first issue of fourth volume, Advancements in Life Sciences has published multidisciplinary scholarly research papers from the fields of Biotechnology, Health, Microbiology and Molecular Biology. This time we focused Plant Functional Genomics. All of the contents can be accessed openly. Enjoy reading! Volume 4, Issue 1 (25 November 2016) In-Focus Functional characterization of fifteen hundred transcripts from …
14 – 20 November 2016 CRISPR gene-editing tested in a person for the first time On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells by CRISPR gene-editing into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, …
07 – 13 November 2016 How scientists reacted to the US election results Nature rounds up reaction from researchers to Donald Trump's election as the next US president. Trump, a Republican, had trailed his Democratic opponent, Hillary Clinton, in polls leading up to the 8 November election day, but pulled out a surprising victory. Find source …
31 October – 06 November 2016 New Alzheimer's drug hit a milestone in a human clinical trial A new drug that targets toxic amyloid proteins in the brain – one of the main hallmarks of Alzheimer’s disease – has produced such promising results in a small clinical trial. Find source USDA Approves Genetically Engineered Potatoes The …
24 – 30 October 2016 Gene drives The University of San Diego is spearheading a new $70-million programme of research on gene drives, which can be used to spread mutations through wild populations and could in theory be used to control diseases like malaria. Find source Modified Mosquitoes vs. Zika Mosquitoes that carry Wolbachia bacteria — …
17 – 23 October 2016 Stanford Medicine will build America’s first hadron therapy center Hadron therapy, which relies on beams of charged particles including protons and heavier ions such as carbon, is expected to increase cancer cure rates because it can be used to treat larger tumors or those resistant to conventional radiotherapy. Find source Mouse eggs …
10 – 16 October 2016 WHO warns that Zika virus is likely to spread in Asia Zika infections are “highly likely” to keep spreading in Asia, the World Health Organization (WHO) has warned. Hundreds of cases of the virus have been reported in Singapore. Find source Safety concerns blight promising cancer therapy A groundbreaking …
advertisement area
advertisement area
